Zynex Welcomes New CEO Steven Dyson and Enhanced Leadership Team

Zynex, Inc., a prominent innovator in medical technology known for its non-invasive medical devices, has recently announced significant leadership changes. On August 18, 2025, the company revealed that Steven Dyson has taken the helm as its new Chief Executive Officer. With Dyson’s appointment, Zynex aims to revitalize its operations and enhance the quality of care that it offers to patients suffering from chronic pain and other health challenges.

A New Era for Zynex

Steven Dyson’s transition into the role of CEO represents a pivotal moment for Zynex. Since June 30, 2025, Dyson has been collaborating closely with Thomas Sandgaard, the Chairman of the Board, to assemble a new executive team, marking the beginning of a strategic shift within the company. The new leadership roster also includes Vikram Bajaj as Chief Financial Officer (CFO), John T. Bibb as Chief Legal Officer, Ajay Gopal as Executive Vice President of Sales, and Agnes Powell as Vice President of Billing. Each of these individuals brings a wealth of experience that is expected to contribute to Zynex’s mission of delivering high-quality medical solutions.

Introducing the New Executive Team

Vikram Bajaj joins Zynex with over 20 years of robust experience in financial strategy and management within the medical technology sector. His previous roles include significant positions as CFO of Vyaire Medical and at Kinetic Concepts (KCI). With a background in public accounting from Arthur Andersen, he holds a Chartered Accountant designation which will be valuable as Zynex navigates the financial intricacies of the med-tech market.

John T. Bibb, the newly appointed Chief Legal Officer, adds over two decades of legal, compliance, and human resources expertise in the med-tech domain. Bibb has held executive roles at companies such as LifeCell and Vyaire Medical, and his insight into compliance and regulatory matters will be crucial as Zynex strives to maintain its ethical standards and legal obligations.

Ajay Gopal takes on the role of EVP of Sales, where he is set to leverage his successful track record at KCI and Danaher to drive commercial growth. His proven leadership and ability to foster team synergy will be essential as Zynex works to enhance product access and meet market demands.

Agnes Powell, the new VP of Billing, is another seasoned professional joining the team. With two decades of expertise in revenue cycle management across various healthcare settings, she brings invaluable skills in improving billing processes and ensuring compliance with ever-changing regulations.

A Shared Vision for the Future

Under Dyson’s leadership, the executive team aims to elevate Zynex’s business performance over the forthcoming quarters. Dyson expressed optimism about the recent additions, highlighting their collective experience and commitment to integrity and quality in business practices. He stated, "We have a lot to do to improve business performance at the Company over the coming quarters. I believe we now have the right team in place to deliver excellent results in the future."

Thomas Sandgaard echoed this sentiment, expressing confidence in Dyson's leadership and the competence of the new executive team. He emphasized that their experience and proven track record will be instrumental in guiding Zynex into a successful future, aligning with the company’s commitment to improving patients' lives.

Looking Ahead

As Zynex transitions into this new chapter, the company remains focused on its mission of developing innovative medical devices aimed at pain management and rehabilitation. With a team of experienced leaders now in place, Zynex is poised to tackle industry challenges head-on. Stakeholders and patients alike can look forward to enhanced operational efficiencies and an unwavering commitment to quality patient care.

For more information about Zynex and its innovative medical solutions, visit Zynex's official website. This leadership transformation marks just the beginning of Zynex's efforts to lead the way in medical technology advancements.